Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001252004-25-000005
Filing Date
2025-10-03
Accepted
2025-10-03 16:16:18
Documents
1
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1759522571.html 4  
1 FORM 4 wk-form4_1759522571.xml 4 6986
  Complete submission text file 0001252004-25-000005.txt   8576
Mailing Address C/O VERACYTE, INC. 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
EPSTEIN ROBERT S (Reporting) CIK: 0001252004 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36156 | Film No.: 251374070

Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)